The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Treatment of Depression in Cancer Patients

Integrated psychosocial and pharmacologic care for major depressive disorder during cancer therapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Treatment of Depression in Cancer Patients?

Major depressive disorder affects up to twenty percent of patients with cancer and varies by site, stage, and treatment phase. It is associated with poor adherence to oncologic therapy, increased symptom burden, reduced quality of life, and elevated mortality. Recognition is hampered by overlap with cancer-related fatigue, anorexia, and insomnia.

Validated tools such as the Patient Health Questionnaire and Hospital Anxiety and Depression Scale support routine screening and stepped care. Comprehensive evaluation distinguishes major depressive disorder from adjustment disorder, demoralization, hypoactive delirium, and medication-induced depressive symptoms.

Treatment uses collaborative care models that integrate behavioral health into oncology practice. Cognitive behavioral therapy, problem-solving therapy, and supportive expressive therapy improve depression and quality of life. Pharmacotherapy selects antidepressants such as escitalopram, sertraline, mirtazapine, or duloxetine based on symptom predominance, comorbidity, and drug-drug interaction profile with chemotherapy or supportive medications.

Symptoms

Persistent low mood for two weeks or more
Loss of interest in previously enjoyable activities
Hopelessness or worthlessness
Sleep and appetite disturbance beyond cancer effect
Suicidal thoughts requiring urgent assessment

Risk Factors

Advanced or terminal stage cancer
Pancreatic, head and neck, or brain malignancy
Pre-existing psychiatric history
Younger age at diagnosis
Limited social support

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When persistent low mood lasts two weeks
  • When activities of daily living are impaired
  • When suicidal thoughts arise
  • When prior depression worsens during treatment
  • When sleep or appetite changes exceed cancer effect

Treatment Methods

01
Validated screening with PHQ-9 and HADS
02
Collaborative care behavioral integration
03
Cognitive behavioral or problem-solving therapy
04
Selective serotonin reuptake inhibitor or SNRI
05
Mirtazapine for insomnia and weight loss
06
Drug-interaction review with oncology medications
07
Suicide risk assessment and safety planning

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.